1De Zeeuw D. Renal disease: a common and a silent killer. Nat Clin Pract Cardiovasc Med ,2008,5 :$27-35.
2Ritz E, McClellan WM. Overview:increased cardiovascular risk in patients with minor renal dysfunction:an emerging issue with far-reaching consequences. J Am Soc Nephrol,2004,15 :513-516.
3Go AS, Chertow GM, Fan D,et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med ,2004,351 : 1296-1305.
4Mann JF,Gerstein HC, Pogue J, et al. Cardiovascular risk in patients with early renal insufficiency: implications for the use of ACE inhibitors . Am J Cardiovasc Drugs ,2002,2 (3) :157-162.
5Munster P, He J, Hamm L, et al. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol,2002,13:745-753.
6Manjunath G,Tighiouart H,Ibrahim H,et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular disease in the community. J Am Coll Cardiol,2003,41 ( 1 ) :47-55.
7Sarnak MJ,Levey AS,Schoolwerth AC,et al. Kidney disease as a risk factor for factor for development of cardiovascular disease : a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation, 2003, 108: 2154- 2169.
8Ridker PM, Cushman M ,Stampfer MT, et al. Inflammation, asprin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med,1997,336(14) :973-979.
9Cottone S,Lorito MC, Rieeobene R,et al. Oxidative stress,inflammation and cardiovascular disease in chronic renal failure. J Nephrol, 2008,21: 175-179.
10Shah SV, Baliga R,Rajapurkar M,et al. Oxidants in chronic kidney disease. J Am Soc Nephrol,2007,18(1) :16-28.
7Samak MJ,Levey AS,Schoolwerth AC,et al. Kidney disease as a risk factor for development of cardiovascular disease; a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension,2003,42:1050-1065.
8Theroux P. Perspectives on acute coronary syndromes. Can J Cardiol, 2005,21:1053-1060.
9Feit F,Voeltz MD,Attubato MJ,et al. Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial. Am J Cardiol,2007,100; 1364-1369.
10Tonelli M,Wiebe N,Culleton B,et al. Chronic kidney disease and mortality risk;a systematic review. J Am Soc Nephrol,2006,17 ;2034-2047.
